MIRAE ASSET SECURITIES (USA) INC.’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
MIRAE ASSET SECURITIES (USA) INC.'s MRNA Position: Q4 2025 in Review
MIRAE ASSET SECURITIES (USA) INC. sold out of Moderna (MRNA) in Q4 2025, closing a stake of 113,276 shares — an estimated $2.93M sold.
MIRAE ASSET SECURITIES (USA) INC. first reported a position in MRNA in Q4 2024 and held it in 2 quarters. The position peaked at $8.34M in Q4 2024. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.
- MIRAE ASSET SECURITIES (USA) INC. reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
- MIRAE ASSET SECURITIES (USA) INC. sold 113,276 Moderna shares in Q4 2025, an estimated $2.93M.
- MIRAE ASSET SECURITIES (USA) INC. first reported a position in Moderna in Q4 2024 and held it in 2 quarters.
- MIRAE ASSET SECURITIES (USA) INC.'s Moderna position peaked at $8.34M in Q4 2024.
- 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.
Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q4 2025, filed 11 Feb 2026.